Offer - Urjas Oil for just ₹ 1
Epitaz 100 Injection is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Breast Cancer.
The right dosage of Epitaz 100 Injection depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Epitaz 100 Injection have been listed ahead. Normally, these side effects of Epitaz 100 Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Epitaz 100 Injection has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Epitaz 100 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Other contraindications of Epitaz 100 Injection have been discussed in the sections ahead.
Drug interactions for Epitaz 100 Injection have been reported in the medical literature. See below for a complete list.
You should also be aware that Epitaz 100 Injection is not safe while driving, and is not addiction.
Epitaz 100 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
| Geriatric |
|
Is the use of Epitaz 100 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Epitaz. If you are pregnant, do not take Epitaz without a doctor's advice.
Is the use of Epitaz 100 Injection safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Epitaz. So it is adviced to consult the doctor before using it.
What is the effect of Epitaz 100 Injection on the Kidneys?
Epitaz may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Epitaz 100 Injection on the Liver?
The liver can be affected by Epitaz. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Epitaz only after medical advice.
What is the effect of Epitaz 100 Injection on the Heart?
You may experience side effects on your heart after taking Epitaz. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Epitaz 100 Injection unless your doctor advises you to do so -
Is this Epitaz 100 Injection habit forming or addictive?
No, you will not get addicted to Epitaz 100 Injection.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Epitaz 100 Injection. So it is best to avoid driving.
Is it safe?
Yes, Epitaz 100 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Epitaz 100 Injection in mental disorders is not effective.
Interaction between Food and Epitaz 100 Injection
You can take Epitaz 100 Injection with food.
Interaction between Alcohol and Epitaz 100 Injection
Consult your doctor before consuming alcohol while taking Epitaz 100 Injection as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ellence® (epirubicin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 867
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 505-508
